ABL Bio Inc. (298380.KQ) KOE

191,400.00

-9600(-4.78%)

Updated at December 05 10:42AM

Currency In KRW

Valuation

Market Cap1.44T
Enterprise Value1.42T
P/E Ratio-162.74
PEG Ratio-2.29
Price/Sales Ratio102.75
Price/Book Ratio53.04
Enterprise/Revenue101.81
Enterprise/EBITDA-551.43

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.63
Operating Margin-0.23

Management Effectiveness

Return On Assets-0.25
Return On Equity-0.36

Income Statement

Revenue33.4B
Revenue/Share1,957.05
Gross Profit33.4B
EBITDA-53.15B
Net Income-55.53B
Diluted EPS-1,157.23

Balance Sheet

Total Cash137.86B
Total Cash/Share2,842
Total Debt43.38B
Total Debt/Equity0.24
Current Ratio2.35
Book Value Per Share3,789.73

Price History

52-Week Change602.8
52-Week High204,500
52-Week Low26,350
Moving Average 50 Days121,150
Moving Average 200 Days79,436

Statistics

Average Volume1.11M
Shares Outstanding48.53M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A